← BMJ Neurology Open

Papers in BMJ Neurology Open

Page 3 · newest first

101. Understanding dopaminergic dose reduction following STN-DBS: mediation analysisBMJ Neurology Open · 2026
102. New-onset refractory status epilepticus associated with Sjögren’s diseaseBMJ Neurology Open · 2026
103. Pilot randomised controlled trial of a novel form of exercise on parkinsonism symptomsBMJ Neurology Open · 2026
104. GLUT1 deficiency syndrome in adulthood: lost in diagnosisBMJ Neurology Open · 2026
105. Evaluation of cortical pathology in primary-progressive multiple sclerosis: a post hoc analysis of the SPRINT-MS trialBMJ Neurology Open · 2026
106. Introducing the SAGE study: a multimodal protocol for testing a GABAergic mechanism of age-related episodic memory impairment across the sexesBMJ Neurology Open · 2026
107. Primary central nervous system T-cell lymphoma: a single-centre retrospective study and literature reviewBMJ Neurology Open · 2026
108. Lamotrigine serum concentrations as longitudinal biomarkers for seizure risk prediction in pregnant women with epilepsy: a secondary analysis of the EMPiRE studyBMJ Neurology Open · 2026
109. Development and validation of predictive models for 6-month gastrostomy timing in amyotrophic lateral sclerosisBMJ Neurology Open · 2026
110. Prospective assessment of serum neurofilament light chain in platinum-induced and taxane-induced peripheral neuropathyBMJ Neurology Open · 2026
111. Timing matters when using paraclinical tests to assess for optic neuritis under the 2024 McDonald criteriaBMJ Neurology Open · 2026
112. Correlation of Gray-to-White matter ratio on Non-Contrast CT with neurological outcome in Post-Cardiac arrest syndromeBMJ Neurology Open · 2026
113. Access to care for adults living with spinal muscular atrophy in the UKBMJ Neurology Open · 2026
114. Stroke risk in patients with hypertensive retinopathy: a systematic review and meta-analysisBMJ Neurology Open · 2026
115. Study protocol for a prospective, cluster randomised control, hybrid type 1 effectiveness-implementation trial to evaluate the R eduction O f S eizures through E ducation and S upport: the ROSES studyBMJ Neurology Open · 2026
116. Parkinson’s disease care in Pakistan: overcoming challenges in low- and middle-income countriesBMJ Neurology Open · 2026
117. What is refractory CIDP?BMJ Neurology Open · 2026
118. Stiff-person spectrum disorder induced by shingles: a case reportBMJ Neurology Open · 2025
119. Clinical and genetic analysis of a family with myopathy caused by an FHL1 gene variantBMJ Neurology Open · 2025
120. Severe hyperCKaemia and decreased sarcolemmal dysferlin in VRK1-associated distal spinal muscular atrophy: a case reportBMJ Neurology Open · 2025
121. Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapyBMJ Neurology Open · 2025
122. Exploring rituximab for the treatment of refractory myasthenia gravis: a single-centre experienceBMJ Neurology Open · 2025
123. Neurological involvement in primary Sjögren’s syndrome: a retrospective analysis of clinical, radiological, laboratory and therapeutic correlationsBMJ Neurology Open · 2025
124. Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)BMJ Neurology Open · 2025
125. Organisational impact and patient management models for biomarker integration in multiple sclerosis care in Italy: the 0Tolerance projectBMJ Neurology Open · 2025
126. Relationship between personality and poststroke functional outcomes: a systematic reviewBMJ Neurology Open · 2025
127. Subgroup analysis of tumefactive demyelinating lesions: clinical, imaging features and outcomesBMJ Neurology Open · 2025
128. Gender differences in depression, anxiety, and quality of life in Parkinson’s disease before and after deep brain stimulation surgery: a multicentre cohort studyBMJ Neurology Open · 2025
129. Optic nerve as a 5th location in the revised McDonald diagnostic criteria for multiple sclerosis: limitations of OCT in the acute phaseBMJ Neurology Open · 2025
130. Reducing hospital length of stay with criteria-led transfer from the acute stroke unit to inpatient rehabilitationBMJ Neurology Open · 2025
131. Density of routinely collected neurology data depends on patient visit type: an investigation using the observational medical outcomes partnership common data modelBMJ Neurology Open · 2025
132. Whole Exome Sequencing Identifies Novel Homozygous LGI1 Variant Mimicking ADAM22 -Related Pathologies in a Moroccan FamilyBMJ Neurology Open · 2025
133. Public and professional attitudes towards deceptive and open-label placebo in functional neurological disorder and wider neurological practiceBMJ Neurology Open · 2025
134. Effect of deep brain stimulation on patients with Parkinson’s disease with excessive daytime sleepinessBMJ Neurology Open · 2025
135. Integrated UPper limb and Language Impairment and Functional Training (UPLIFT) after stroke: study protocol for an umbrella Bayesian Optimal Phase IIa clinical trialBMJ Neurology Open · 2025
136. Burden of Duchenne muscular dystrophy in Australia: a scoping reviewBMJ Neurology Open · 2025
137. Advances in functional Neurological disorderBMJ Neurology Open · 2025
138. Evaluation of outcomes for patients with nitrous oxide-related myeloneuropathy treated with self-injection of hydroxocobalamin versus nurse-led injections on an ambulatory care pathwayBMJ Neurology Open · 2025
139. Understanding the progression of Parkinson’s disease: a reviewBMJ Neurology Open · 2025
140. Efgartigimod following plasma exchange in the treatment of subjects with generalised myasthenia gravis: study protocol for a multicentre, three-arm, open-label studyBMJ Neurology Open · 2025
141. Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson’s disease without dementia: a systematic reviewBMJ Neurology Open · 2025
142. Obstructive sleep apnoea and risk of dementia: a Danish population-based cohort studyBMJ Neurology Open · 2025
143. Plasma cell-free DNA testing in diagnosing Listeria rhombencephalitis in a CSF PCR-negative patient: a case reportBMJ Neurology Open · 2025
144. Transplacental transfer of ravulizumab in a pregnant woman with neuromyelitis optica: a case reportBMJ Neurology Open · 2025
145. Neuronal intranuclear inclusion disease with subtle imaging findings: a case report and literature reviewBMJ Neurology Open · 2025
146. Urinary P75: a promising biomarker for amyotrophic lateral sclerosisBMJ Neurology Open · 2025
147. Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccinationBMJ Neurology Open · 2025
148. Evaluation and treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathyBMJ Neurology Open · 2025
149. Data-driven targets for predicting outcomes in patients with HIV infection and tuberculous meningitis in ChinaBMJ Neurology Open · 2025
150. Effect of anticoagulation on the age distribution of thrombi in stroke patients with non-valvular atrial fibrillationBMJ Neurology Open · 2025